Global Mesenchymal Stem Cells Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Mesenchymal Stem Cells market size will reach 250.63 Million USD in 2025 and is projected to reach 347.06 Million USD by 2032, with a CAGR of 4.76% (2025-2032). Notably, the China Mesenchymal Stem Cells market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Mesenchymal stem cells (MSCs) are a type of adult stem cell that can be found in various tissues of the body, including bone marrow, adipose tissue (fat), umbilical cord, and dental pulp. These unique cells have the remarkable ability to differentiate into different cell types, such as bone cells, cartilage cells, and fat cells, among others. MSCs also possess immunomodulatory properties, meaning they can modulate the immune response and regulate inflammation. Additionally, they secrete various signaling molecules and growth factors that can promote tissue repair, angiogenesis (formation of new blood vessels), and wound healing. Due to these characteristics, MSCs have gained significant attention in regenerative medicine and tissue engineering, with potential applications in the treatment of various conditions such as bone and cartilage defects, autoimmune diseases, and chronic inflammatory disorders. MSC-based therapies involve harvesting the cells from a suitable source, expanding them in the lab, and then delivering them to the target tissue either through direct injection or systemic infusion. Research in the field of MSCs is ongoing, and scientists continue to explore their potential benefits and optimal methods for their therapeutic applications.
The major global manufacturers of Mesenchymal Stem Cells include Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen, Cyagen Biosciences, Cell Applications, Axol Bioscience, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Mesenchymal Stem Cells. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Mesenchymal Stem Cells market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Mesenchymal Stem Cells market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Mesenchymal Stem Cells industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Mesenchymal Stem Cells Include:
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cyagen Biosciences
Cell Applications
Axol Bioscience
Mesenchymal Stem Cells Product Segment Include:
Human MSC
Mouse MSC
Rat MSC
Others
Mesenchymal Stem Cells Product Application Include:
Research Institute
Hospital
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Mesenchymal Stem Cells Industry PESTEL Analysis
Chapter 3: Global Mesenchymal Stem Cells Industry Porter's Five Forces Analysis
Chapter 4: Global Mesenchymal Stem Cells Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Mesenchymal Stem Cells Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Mesenchymal Stem Cells Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Mesenchymal Stem Cells Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Mesenchymal Stem Cells market size will reach 250.63 Million USD in 2025 and is projected to reach 347.06 Million USD by 2032, with a CAGR of 4.76% (2025-2032). Notably, the China Mesenchymal Stem Cells market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Mesenchymal stem cells (MSCs) are a type of adult stem cell that can be found in various tissues of the body, including bone marrow, adipose tissue (fat), umbilical cord, and dental pulp. These unique cells have the remarkable ability to differentiate into different cell types, such as bone cells, cartilage cells, and fat cells, among others. MSCs also possess immunomodulatory properties, meaning they can modulate the immune response and regulate inflammation. Additionally, they secrete various signaling molecules and growth factors that can promote tissue repair, angiogenesis (formation of new blood vessels), and wound healing. Due to these characteristics, MSCs have gained significant attention in regenerative medicine and tissue engineering, with potential applications in the treatment of various conditions such as bone and cartilage defects, autoimmune diseases, and chronic inflammatory disorders. MSC-based therapies involve harvesting the cells from a suitable source, expanding them in the lab, and then delivering them to the target tissue either through direct injection or systemic infusion. Research in the field of MSCs is ongoing, and scientists continue to explore their potential benefits and optimal methods for their therapeutic applications.
The major global manufacturers of Mesenchymal Stem Cells include Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen, Cyagen Biosciences, Cell Applications, Axol Bioscience, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Mesenchymal Stem Cells. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Mesenchymal Stem Cells market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Mesenchymal Stem Cells market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Mesenchymal Stem Cells industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Mesenchymal Stem Cells Include:
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cyagen Biosciences
Cell Applications
Axol Bioscience
Mesenchymal Stem Cells Product Segment Include:
Human MSC
Mouse MSC
Rat MSC
Others
Mesenchymal Stem Cells Product Application Include:
Research Institute
Hospital
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Mesenchymal Stem Cells Industry PESTEL Analysis
Chapter 3: Global Mesenchymal Stem Cells Industry Porter's Five Forces Analysis
Chapter 4: Global Mesenchymal Stem Cells Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Mesenchymal Stem Cells Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Mesenchymal Stem Cells Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Mesenchymal Stem Cells Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Mesenchymal Stem Cells Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Mesenchymal Stem Cells Product by Type
- 1.2.1 Human MSC
- 1.2.2 Mouse MSC
- 1.2.3 Rat MSC
- 1.2.4 Others
- 1.3 Mesenchymal Stem Cells Product by Application
- 1.3.1 Research Institute
- 1.3.2 Hospital
- 1.3.3 Others
- 1.4 Global Mesenchymal Stem Cells Market Revenue and Sales Analysis
- 1.4.1 Global Mesenchymal Stem Cells Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Mesenchymal Stem Cells Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Mesenchymal Stem Cells Market Sales Price Trend Analysis (2020-2032)
- 1.5 Mesenchymal Stem Cells Market Development Status and Trends
- 1.5.1 Mesenchymal Stem Cells Industry Development Status Analysis
- 1.5.2 Mesenchymal Stem Cells Industry Development Trends Analysis
- 2 Mesenchymal Stem Cells Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Mesenchymal Stem Cells Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Mesenchymal Stem Cells Market Analysis by Country
- 4.1 Global Mesenchymal Stem Cells Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Mesenchymal Stem Cells Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Mesenchymal Stem Cells Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Mesenchymal Stem Cells Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Mesenchymal Stem Cells Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Mesenchymal Stem Cells Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Mesenchymal Stem Cells Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Mesenchymal Stem Cells Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Mesenchymal Stem Cells Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Mesenchymal Stem Cells Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Mesenchymal Stem Cells Average Sales Price by Manufacturers (2021-2025)
- 5.2 Mesenchymal Stem Cells Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Mesenchymal Stem Cells Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Mesenchymal Stem Cells Market Analysis by Type
- 6.1 Global Mesenchymal Stem Cells Market Revenue Analysis by Type
- 6.1.1 Global Mesenchymal Stem Cells Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Mesenchymal Stem Cells Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Mesenchymal Stem Cells Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Mesenchymal Stem Cells Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Lonza
- 7.1.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Lonza Mesenchymal Stem Cells Product Portfolio
- 7.1.3 Lonza Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Thermo Fisher
- 7.2.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
- 7.2.3 Thermo Fisher Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Bio-Techne
- 7.3.1 Bio-Techne Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Bio-Techne Mesenchymal Stem Cells Product Portfolio
- 7.3.3 Bio-Techne Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 ATCC
- 7.4.1 ATCC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 ATCC Mesenchymal Stem Cells Product Portfolio
- 7.4.3 ATCC Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 MilliporeSigma
- 7.5.1 MilliporeSigma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
- 7.5.3 MilliporeSigma Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 PromoCell GmbH
- 7.6.1 PromoCell GmbH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
- 7.6.3 PromoCell GmbH Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Genlantis
- 7.7.1 Genlantis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Genlantis Mesenchymal Stem Cells Product Portfolio
- 7.7.3 Genlantis Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Celprogen
- 7.8.1 Celprogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Celprogen Mesenchymal Stem Cells Product Portfolio
- 7.8.3 Celprogen Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Cyagen Biosciences
- 7.9.1 Cyagen Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
- 7.9.3 Cyagen Biosciences Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Cell Applications
- 7.10.1 Cell Applications Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Cell Applications Mesenchymal Stem Cells Product Portfolio
- 7.10.3 Cell Applications Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Axol Bioscience
- 7.11.1 Axol Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
- 7.11.3 Axol Bioscience Mesenchymal Stem Cells Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Mesenchymal Stem Cells Industry Chain Analysis
- 8.2 Mesenchymal Stem Cells Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Mesenchymal Stem Cells Product Downstream Application Analysis
- 8.3.1 Global Mesenchymal Stem Cells Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Mesenchymal Stem Cells Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Mesenchymal Stem Cells Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Mesenchymal Stem Cells Typical Downstream Customers
- 8.5 Mesenchymal Stem Cells Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
